EGFR and cancer: Similarly, Eom et al. (2024) engineered porous SpyCatcher-mi3 protein cage nanoparticles as modular delivery platforms, post-displaying affibodies for ligand-targeted cargo release in therapeutic applications, enabling precise targeting and delivery of chemotherapeutic agents to EGFR-overexpressing cancer cells [69].